Replies to post #201610 on NorthWest Biotherapeutics Inc (NWBO)

[H2R]

Hi Lykiri,

Am I reading this correctly?

" Glioblastoma is the most aggressive brain cancer type, with the worst prognosis; median survival duration is 6 months, and at 2 years after diagnosis, the survival estimate is 10%."

At 3 years, it's 6%.
Sounds like awful stats.



They then have conditions like "If survived 'n' years, then survival..." and "age" but from the initial diagnosis, put in the light of 'survival at n years', it sounds even more ominous than what I had in mind.
DCVax looks pretty incredible.

Best of luck to Patients, NWBO, and Longs!